BGI Genomics Co Ltd (300676) - Total Liabilities

Latest as of September 2025: CN¥2.93 Billion CNY ≈ $428.69 Million USD

Based on the latest financial reports, BGI Genomics Co Ltd (300676) has total liabilities worth CN¥2.93 Billion CNY (≈ $428.69 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of BGI Genomics Co Ltd to assess how effectively this company generates cash.

BGI Genomics Co Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how BGI Genomics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check BGI Genomics Co Ltd (300676) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

BGI Genomics Co Ltd Competitors by Total Liabilities

The table below lists competitors of BGI Genomics Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Meshek Energy-Renewable Energies Ltd TA:MSKE	Israel	ILA1.82 Billion
Home Product Center Public Company Limited BK:HMPRO	Thailand	฿39.37 Billion
Santos Brasil Participações S.A SA:STBP3	Brazil	R$4.72 Billion
OneStream, Inc. Class A Common Stock NASDAQ:OS	USA	$386.58 Million
Triputra Agro Persada Tbk PT JK:TAPG	Indonesia	Rp3.01 Trillion
West African Resources Ltd AU:WAF	Australia	AU$806.24 Million
RH NYSE:RH	USA	$4.79 Billion
Delek US Energy Inc NYSE:DK	USA	$6.30 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down BGI Genomics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of BGI Genomics Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BGI Genomics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BGI Genomics Co Ltd (2012–2024)

The table below shows the annual total liabilities of BGI Genomics Co Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.27 Billion ≈ $478.60 Million	-9.37%
2023-12-31	CN¥3.61 Billion ≈ $528.11 Million	-13.08%
2022-12-31	CN¥4.15 Billion ≈ $607.55 Million	-13.73%
2021-12-31	CN¥4.81 Billion ≈ $704.26 Million	-6.90%
2020-12-31	CN¥5.17 Billion ≈ $756.43 Million	+242.77%
2019-12-31	CN¥1.51 Billion ≈ $220.68 Million	+50.95%
2018-12-31	CN¥999.04 Million ≈ $146.19 Million	+17.00%
2017-12-31	CN¥853.88 Million ≈ $124.95 Million	+9.82%
2016-12-31	CN¥777.52 Million ≈ $113.78 Million	+4.88%
2015-12-31	CN¥741.37 Million ≈ $108.49 Million	+27.08%
2014-12-31	CN¥583.40 Million ≈ $85.37 Million	-35.14%
2013-12-31	CN¥899.46 Million ≈ $131.62 Million	+5.41%
2012-12-31	CN¥853.31 Million ≈ $124.87 Million	--

About BGI Genomics Co Ltd

SHE:300676 China Diagnostics & Research

Market Cap

$2.44 Billion

CN¥16.71 Billion CNY

Market Cap Rank

#5548 Global

#1134 in China

Share Price

CN¥39.94

Change (1 day)

-0.89%

52-Week Range

CN¥38.41 - CN¥59.25

All Time High

CN¥248.01